383 related articles for article (PubMed ID: 37023836)
1. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Li S; Wu X; Ma Y; Zhang H; Chen W
J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
[TBL] [Abstract][Full Text] [Related]
2. Active ingredients of Erhuang Quzhi Granules for treating non-alcoholic fatty liver disease based on the NF-κB/NLRP3 pathway.
Li S; Ma Y; Chen W
Fitoterapia; 2023 Dec; 171():105704. PubMed ID: 37858757
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Effect and Mechanism Prediction of Fuzi-Gancao Herb Couple on Non-alcoholic Fatty Liver Disease (NAFLD) based on Network Pharmacology and Molecular Docking.
Liu K; Yang X; Zhang G; Xiang Z
Comb Chem High Throughput Screen; 2024; 27(5):773-785. PubMed ID: 37317908
[TBL] [Abstract][Full Text] [Related]
5. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
7. Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validation.
Wang Z; Qiu H; Yang Y; Zhang Y; Mou T; Zhang X; Zhang Y
Hereditas; 2024 Apr; 161(1):12. PubMed ID: 38566171
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of Chaenomelis Fructus in treatment of rheumatoid arthritis based on network pharmacology and experimental verification].
Duan ZH; Jin C; Deng Y; Liu JL; Wang J; Li SG; Zhou Y
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4852-4863. PubMed ID: 37802827
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Ganshuang granules on non-alcoholic fatty liver and underlying mechanism: a network pharmacology and experimental verification.
Guoguo Z; Bingjie S; Tianyan Z; Shaoxiu JI; Jingwei LI; Yanni D; Feng L; Dong W
J Tradit Chin Med; 2024 Feb; 44(1):122-130. PubMed ID: 38213247
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment.
Sun CY; Yang LL; Zhao P; Yan PZ; Li J; Zhao DS
Hereditas; 2022 Dec; 159(1):44. PubMed ID: 36451177
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
PeerJ; 2022; 10():e14171. PubMed ID: 36389420
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Huagan Decoction for reflux esophagitis.
Zhao Y; Cao Y; Yang X; Guo M; Wang C; Zhang Z; Zhang Q; Huang X; Sun M; Xi C; Tangthianchaichana J; Bai J; Du S; Lu Y
J Ethnopharmacol; 2022 Nov; 298():115629. PubMed ID: 35988839
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology combines machine learning, molecular simulation dynamics and experimental validation to explore the mechanism of acetylbinankadsurin A in the treatment of liver fibrosis.
Peng W; Yang Y; Lu H; Shi H; Jiang L; Liao X; Zhao H; Wang W; Liu J
J Ethnopharmacol; 2024 Apr; 323():117682. PubMed ID: 38169205
[TBL] [Abstract][Full Text] [Related]
14. An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways.
Wang S; Chen B; Du R; Zhong M; Zhang C; Jin X; Cui X; Zhou Y; Kang Q; Xu H; Li Y; Wu Q; Tong G; Luo L
J Ethnopharmacol; 2024 Jul; 329():118127. PubMed ID: 38583728
[TBL] [Abstract][Full Text] [Related]
15. Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental verification.
Zhi G; Shao B; Zheng T; Mu J; Li J; Feng Y; Zhu S; Dang Y; Liu F; Wang D
Front Pharmacol; 2023; 14():1082451. PubMed ID: 36762105
[No Abstract] [Full Text] [Related]
16. Molecular mechanism of Ginkgo biloba in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations.
Xu S; Tang L; Qian X; Wang Y; Gong J; Yang H; Su D
J Food Biochem; 2022 Dec; 46(12):e14419. PubMed ID: 36121703
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of Xuebijing Injection in treatment of sepsis-associated ARDS based on network pharmacology and in vitro experiment].
Ding WC; Chen J; Liao HY; Feng J; Wang J; Zhang YH; Ji XH; Chen Q; Wu XY; Sun ZR; Nie SN
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3345-3359. PubMed ID: 37382018
[TBL] [Abstract][Full Text] [Related]
18. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
Yang H; Wei D; Zhang Y; Jian W
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
[TBL] [Abstract][Full Text] [Related]
19. Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
Gu M; Su W; Dai J; Wang J; Jia X; Yao J; Zhang G; Zhu Q; Pang Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116899. PubMed ID: 37454750
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of Ganke Granules intervening acute lung injury based on network pharmacology and experimental verification].
Liang H; Li XY; Zhang XW; Bao YW; Ding ML; Yuan QH; He CS; Zeng N
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2197-2209. PubMed ID: 38812235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
